Millions in government funds directed to subsidiaries after Heather Bresch became CEO
Government funds awarded to Mylan, Inc. increased dramatically after the daughter of Sen. Joe Manchin (D., W.Va.) took over as its chief executive officer.
The pharmaceutical company Mylan sparked controversy this week for hiking the price of its EpiPen, an autoinjector used to counter allergic reactions. The life-saving device was sold wholesale at $56.64 per unit in 2009. That price skyrocketed to $317.82 by 2015, an increase of 461 percent. Company executives increased their own salaries as the cost of the EpiPen rose.
Heather Bresch, Manchin’s daughter, served as president of Mylan between 2009 and 2011. She took over as the company’s chief executive officer in 2012.
Bresch was paid $2,453, 456 in salary in 2007. Her total compensation increased to $18,931,068 in 2015, NBC News reported.